Literature DB >> 24990613

Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.

N Weinhold1, A Försti2, M I da Silva Filho3, J Nickel1, C Campo3, P Hoffmann4, M M Nöthen5, D Hose6, H Goldschmidt6, A Jauch7, C Langer8, U Hegenbart1, S O Schönland1, K Hemminki2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24990613     DOI： 10.1038/leu.2014.208

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans.

Authors:  K Hemminki; L Musak; V Vymetalkova; Z Smerhovsky; E Halasova; O Osina; L Letkova; A Försti; L Vodickova; J Buchancova; P Vodicka
Journal:  Leukemia       Date:  2013-11-25       Impact factor: 11.528

2.  Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).

Authors:  Tilmann Bochtler; Ute Hegenbart; Christiane Heiss; Axel Benner; Marion Moos; Anja Seckinger; Stephanie Pschowski-Zuck; Désirée Kirn; Kai Neben; Claus R Bartram; Anthony D Ho; Hartmut Goldschmidt; Dirk Hose; Anna Jauch; Stefan O Schonland
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

3.  Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Authors:  Niels Weinhold; David C Johnson; Andrew C Rawstron; Asta Försti; Chi Doughty; Jayaram Vijayakrishnan; Peter Broderick; Nasrin B Dahir; Dil B Begum; Fay J Hosking; Kwee Yong; Brian A Walker; Per Hoffmann; Thomas W Mühleisen; Christian Langer; Elisabeth Dörner; Karl-Heinz Jöckel; Lewin Eisele; Markus M Nöthen; Dirk Hose; Faith E Davies; Hartmut Goldschmidt; Gareth J Morgan; Kari Hemminki; Richard S Houlston
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

Review 4.  Amyloidosis: pathogenesis and new therapeutic options.

Authors:  Giampaolo Merlini; David C Seldin; Morie A Gertz
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

5.  A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; Wojciech Michowski; Joshua E Elias; Lisa Becks; Frederic Bienvenu; Agnieszka Zagozdzon; Tapasree Goswami; Yaoyu E Wang; Alan B Clark; Thomas A Kunkel; Tanja van Harn; Bing Xia; Mick Correll; John Quackenbush; David M Livingston; Steven P Gygi; Piotr Sicinski
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 6.  Epidemiology of the plasma-cell disorders.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Best Pract Res Clin Haematol       Date:  2007-12       Impact factor: 3.020

7.  Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.

Authors:  Taxiarchis V Kourelis; Shaji K Kumar; Morie A Gertz; Martha Q Lacy; Francis K Buadi; Suzanne R Hayman; Steven Zeldenrust; Nelson Leung; Robert A Kyle; Stephen Russell; David Dingli; John A Lust; Yi Lin; Prashant Kapoor; S Vincent Rajkumar; Arleigh McCurdy; Angela Dispenzieri
Journal:  J Clin Oncol       Date:  2013-10-21       Impact factor: 44.544

8.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

9.  Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.

Authors:  Peter Broderick; Daniel Chubb; David C Johnson; Niels Weinhold; Asta Försti; Amy Lloyd; Bianca Olver; Yussanne Ma; Sara E Dobbins; Brian A Walker; Faith E Davies; Walter A Gregory; J Anthony Childs; Fiona M Ross; Graham H Jackson; Kai Neben; Anna Jauch; Per Hoffmann; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Ian P Tomlinson; Hartmut Goldschmidt; Kari Hemminki; Gareth J Morgan; Richard S Houlston
Journal:  Nat Genet       Date:  2011-11-27       Impact factor: 38.330

10.  The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.

Authors:  Niels Weinhold; David C Johnson; Daniel Chubb; Bowang Chen; Asta Försti; Fay J Hosking; Peter Broderick; Yussanne P Ma; Sara E Dobbins; Dirk Hose; Brian A Walker; Faith E Davies; Martin F Kaiser; Ni L Li; Walter A Gregory; Graham H Jackson; Mathias Witzens-Harig; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Anna Jauch; Hartmut Goldschmidt; Richard S Houlston; Gareth J Morgan; Kari Hemminki
Journal:  Nat Genet       Date:  2013-03-17       Impact factor: 38.330
View more
  3 in total

1.  Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

Authors:  M I da Silva Filho; A Försti; N Weinhold; I Meziane; C Campo; S Huhn; J Nickel; P Hoffmann; M M Nöthen; K-H Jöckel; S Landi; J S Mitchell; D Johnson; G J Morgan; R Houlston; H Goldschmidt; A Jauch; P Milani; G Merlini; D Rowcieno; P Hawkins; U Hegenbart; G Palladini; A Wechalekar; S O Schönland; K Hemminki
Journal:  Leukemia       Date:  2016-12-27       Impact factor: 11.528

2.  Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis.

Authors:  Seok Jin Kim; Hyun-Tae Shin; Hae-Ock Lee; Nayoung K D Kim; Jae Won Yun; Jee Hyang Hwang; Kihyun Kim; Woong-Yang Park
Journal:  Oncotarget       Date:  2016-10-18

3.  The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications.

Authors:  Kari Hemminki; Asta Försti; Raimo Tuuminen; Otto Hemminki; Hartmut Goldschmidt; Kristina Sundquist; Jan Sundquist; Xinjun Li
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.